89 results found

Traditional PTSD treatments lead only half of all patients to remission. Mental health professionals have searched for better ways to help patients who still struggle. Psychedelic treatment now offers new hope for people fighting this challenging condition. Our research on psychedelic therapy shows promising results that could revolutionize PTSD treatment. P...

The increasing public and scientific interest in psychedelics has spurred a broader conversation about their potential therapeutic benefits, especially in the fields of mental health and wellness. Substances like psilocybin (found in magic mushrooms), LSD (lysergic acid diethylamide), DMT (dimethyltryptamine), and ayahuasca are being explored for their poten...

Serotonin, often dubbed the "feel-good" neurotransmitter, plays a pivotal role in regulating our mood, emotions, and overall mental well-being. It is a chemical messenger in the brain that influences a wide range of physiological and psychological functions. From mood regulation to sleep, appetite, and even memory, serotonin impacts many aspects of our daily...

In recent years, the emergence of psychedelic company stocks has captivated investors, especially those interested in new and potentially groundbreaking industries. As research into psychedelic substances like psilocybin, MDMA, and LSD expands, psychedelic companies are making strides in the pharmaceutical, mental health, and wellness sectors. This has led t...

BMB-101 is an innovative drug under development by Bright Minds Biosciences, designed to selectively target the 5-HT2C serotonin receptor. By activating this receptor, BMB-101 aims to address a range of neuropsychiatric conditions, including depression, anxiety, and other mood disorders. Its precise mechanism offers a potential breakthrough in treating condi...

Canada has quietly become a major player in the exciting world of innovative drug development, with a particular focus on improving mental health treatments. Companies like Bright Minds Biosciences are leading the charge, wielding cutting-edge research and technology to tackle complex neurological and psychiatric conditions. Let's explore the landscape of Ca...

Psychedelic therapy represents a revolutionary approach to treating anxiety disorders, offering new hope for those who haven't found sufficient relief with traditional methods. While the field is still young, initial research suggests immense potential for alleviating the burden of anxiety and improving the lives of millions. Continued research, education, a...

Mental illness affects millions globally, impacting daily life and well-being. Thankfully, there's a vast array of therapies available to combat these challenges. Bright Mind Biosciences is a company dedicated to developing next-generation treatments for mental health conditions like depression and anxiety. Their focus lies on the serotonergic system, a netw...

For many longtime smokers, quitting can feel like an insurmountable challenge. Despite the well-known health risks and personal desires to quit, nicotine addiction often proves stubbornly persistent. Traditional methods like patches, gums, and support groups help some, but for others, they fall short. However, recent research suggests an unconventional ally ...

In recent years, there's been a surge of interest in psychedelic microdosing—a practice where individuals take tiny, sub-perceptual amounts of substances like LSD or psilocybin (found in magic mushrooms) every few days. Unlike full doses that induce strong psychedelic experiences, microdoses aim to offer subtle benefits without the intense trip.

Have you ever wondered about the intricate link between your brain and your mental well-being? This is the very question that neuropsychiatry, a captivating field at the crossroads of neuroscience and psychiatry, seeks to answer. In recent years, a new player has emerged on the scene with exciting therapeutic possibilities: psilocybin, the psychoactive compo...

Epilepsy. The word itself can conjure up images of dramatic convulsions, but the reality is far more nuanced. It’s a neurological disorder defined by recurrent seizures – brief episodes of involuntary movement that can affect a part of the body (partial) or the whole body (generalized). It’s surprisingly common, striking people of all ages, backgrounds, and ...